Overview
- Editors:
-
-
Nancy Boucot Cummings
-
National Institutes of Health, Bethesda, USA
-
Saulo Klahr
-
Washington University School of Medicine, St. Louis, USA
Access this book
Other ways to access
Table of contents (60 chapters)
-
-
Studies of Pathogenesis of Renal Disease
-
-
Research Trends in Glomerular Diseases
-
-
- Gary E. Striker, Federico M. Farin, Paul D. Killen, Jeffrey F. Bonadio
Pages 9-14
-
-
-
Cystic Diseases of the Kidney
-
-
-
- Andrew P. Evan, Kenneth D. Gardner Jr.
Pages 55-68
-
-
-
- William M. Bennett, Curtis G. Wickre, Richard S. Muther
Pages 89-93
-
- Larry W. Welling, Dan J. Welling
Pages 95-103
-
- Joseph H. Holmes, Patricia Gabow
Pages 105-112
-
Recent Advances on Some Complications of Chronic Renal Failure
-
Front Matter
Pages 113-113
-
Renal Osteodystrophy, Vitamin D Analogues, Parathormone
-
- Saulo Klahr, Eduardo Slatopolsky, Kevin Martin
Pages 117-125
-
-
- Jacob Lemann Jr., Richard W. Gray, Nancy D. Adams
Pages 139-153
-
- Eduardo Slatopolsky, Kevin Martin, Keith Hruska, Saulo Klahr
Pages 155-163
-
About this book
Chronic renal disease has received increasing attention and concern since the passage in 1972 of PL 92-603, which provided coverage for end-stage renal disease (ESRD) treatment by the federal government. The human and economic costs of the ESRD program serve to emphasize the need to prevent or to arrest those diseases resulting in chronic renal failure, since none of the available treatments is without complications and/or side effects. The ESRD program, the only federal one that provides coverage for a catastrophic illness for almost the entire population (those qualifying under Social Security), cost almost $2 billion in 1983. The escalating costs of the ESRD program are attributed to the increasing number of patients requiring treatment and have focused concerns of the United States Government, both Congress and the administration, on ESRD. The National Institutes of Health (NIH), especially the Kidney, Urology, and Hematology Division of the National Institutes of Arthritis, Diabetes, and Digestive and Kidney Diseases (NIADDK), supports a sizable research program that bears on chronic renal disease and in association with this has sponsored many conferences and workshops on research on and causes and complications of chronic renal failure. This book is an outgrowth of the issues addressed by participants at a number of NIH conferences held in the 1980s.
Editors and Affiliations
-
National Institutes of Health, Bethesda, USA
Nancy Boucot Cummings
-
Washington University School of Medicine, St. Louis, USA
Saulo Klahr